← Back to screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

Rank #1176 · NYSE · $17.3B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
52.6
P/E
36.5
P/B
5.00
ROE
13.7%
Op. Margin
14.9%
Debt Ratio
116%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 36.5x, P/B 5.00x. Ranks in the top 55% of the universe.

Profitability ★★★☆☆
Good

ROE 13.7%. Ranks in the top 32% of the universe.

Safety ★★★☆☆
Average

Debt ratio 116%. Ranks in the top 45% of the universe.

Growth ★★☆☆☆
Average

Revenue growth of 3.9% year over year. Ranks in the top 53% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.2B$0.1B$0.7B–152
2012–$-0.3B$-0.3B$0.5B–196
2013–$0.2B$0.1B$0.6B–164
2014$1.1B$0.2B–$0.6B14.7151
2015$1.2B$0.2B$0.1B$0.7B13.0173
2016$1.3B$0.2B$0.1B$0.7B13.7178
2017$1.4B$0.2B$0.1B$0.8B15.1222
2018$1.7B$0.2B$0.2B$1.0B14.1179
2019$1.9B$0.3B$0.1B$1.3B15.5191
2020$2.3B$0.3B$0.2B$1.6B14.6185
2021$2.6B$0.4B$0.3B$2.1B13.4158
2022$2.9B$0.4B$0.4B$2.5B14.8175
2023$3.5B$0.6B$0.4B$3.0B16.7154
2024$4.0B$0.7B$0.5B$3.6B16.4126
2025$4.1B$0.6B$0.5B$3.5B14.9116

← See the full screener